DBV Technologies S.A.
DBVTF- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesDBVT
Holders of 5% or more of DBVTF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of DBV Technologies S.A., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of DBV Technologies S.A. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on DBV Technologies S.A., newest first.
No Schedule 13D or 13G filings on DBV Technologies S.A. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell DBV Technologies S.A. shares.
No Form 144 notices for DBV Technologies S.A. are on file.